Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market

Pfizer's drug Velsipity (etrasimod), for the treatment of moderate to severe ulcerative colitis (UC), recently received approval from the UK's Medicines and Healthcare products Regulatory Agency (MHRA).